Caplight Directory>Companies>Nionyx Bio-preview>Nionyxbio


Nionyx Bio

Nionyx Bio

Private
New York City, New YorkHealthcare & Life Scienceshttps://nionyxbio.com/

Last Round

Seed

Sep 29, 2025

Total Funding Raised

$4M

Momentum Score

50 /100

Company Overview

Nionyx Bio is a biotechnology company that builds AAV-based genetic medicines to address kidney genetic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

AAV gene therapyrenal gene therapykidney disease treatmentAAV capsid platformgene therapyAAVadeno-associated virusAAV capsid engineeringgene deliverypreclinical biotechkidney tropismtissue-targeted therapyAAV Kidney Atlasplatform licensingdrug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nionyx Bio Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Nionyx Bio Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedSep 29, 2025
View all Funding Rounds

Key People

Founding team and executive leadership

Magdalena Tyrpien

Co-Founder CEO

Founding Team

Nionyx Bio Investors

Notable investors and investment history

InvestorRounds
Empire State DevelopmentSeed
Pathway BioventuresSeed
2048 VenturesSeed
AIN VenturesSeed
View all Investors

Nionyx Bio Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nionyx Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nionyx Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range5
Year Founded2025
Last FundingSep 29, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.